Sanofi Statistics

Share Statistics

Sanofi has 2.48B shares outstanding. The number of shares has increased by -0.67% in one year.

Shares Outstanding	2.48B
Shares Change (YoY)	-0.67%
Shares Change (QoQ)	1.74%
Owned by Institutions (%)	18.87%
Shares Floating	2.19B
Failed to Deliver (FTD) Shares	11
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 4.93M, so 0.2% of the outstanding shares have been sold short.

Short Interest	4.93M
Short % of Shares Out	0.2%
Short % of Float	0.23%
Short Ratio (days to cover)	1.37

Valuation Ratios

The PE ratio is 20.97 and the forward PE ratio is 10.4. Sanofi's PEG ratio is 11.3.

PE Ratio	20.97
Forward PE	10.4
PS Ratio	2.63
Forward PS	2.2
PB Ratio	1.5
P/FCF Ratio	19.8
PEG Ratio	11.3

Financial Ratio History

Enterprise Valuation

Sanofi has an Enterprise Value (EV) of 127.03B.

EV / Sales	2.87
EV / EBITDA	11.51
EV / EBIT	13.99
EV / FCF	21.58

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.

Current Ratio	1.46
Quick Ratio	1.14
Debt / Equity	0.23
Debt / EBITDA	1.62
Debt / FCF	3.04
Interest Coverage	19.29

Financial Efficiency

Return on Equity is 7.17% and Return on Invested Capital is 10.99%.

Return on Equity	7.17%
Return on Assets	4.19%
Return on Invested Capital	10.99%
Revenue Per Employee	$534.35K
Profits Per Employee	$67.09K
Employee Count	82,878
Asset Turnover	0.33
Inventory Turnover	1.4

Taxes

Income Tax	1.2B
Effective Tax Rate	17.82%

Stock Price Statistics

The stock price has increased by -8.24% in the last 52 weeks. The beta is 0.44, so Sanofi's price volatility has been higher than the market average.

Beta	0.44
52-Week Price Change	-8.24%
50-Day Moving Average	48.21
200-Day Moving Average	50.91
Relative Strength Index (RSI)	65.58
Average Volume (20 Days)	2,982,730

Income Statement

In the last 12 months, Sanofi had revenue of 44.29B and earned 5.56B in profits. Earnings per share was 2.19.

Revenue	44.29B
Gross Profit	31.08B
Operating Income	14.45B
Net Income	5.56B
EBITDA	11.03B
EBIT	7.45B
Earnings Per Share (EPS)	2.19

Full Income Statement

Balance Sheet

The company has 7.44B in cash and 17.91B in debt, giving a net cash position of -10.46B.

Cash & Cash Equivalents	7.44B
Total Debt	17.91B
Net Cash	-10.46B
Retained Earnings	n/a
Total Assets	124.96B
Working Capital	7.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.08B and capital expenditures -3.19B, giving a free cash flow of 5.89B.

Operating Cash Flow	9.08B
Capital Expenditures	-3.19B
Free Cash Flow	5.89B
FCF Per Share	2.35

Full Cash Flow Statement

Margins

Gross margin is 70.18%, with operating and profit margins of 32.63% and 12.55%.

Gross Margin	70.18%
Operating Margin	32.63%
Pretax Margin	15.26%
Profit Margin	12.55%
EBITDA Margin	24.91%
EBIT Margin	32.63%
FCF Margin	13.29%

Dividends & Yields

SNY pays an annual dividend of $4.25, which amounts to a dividend yield of 4.43%.

Dividend Per Share	$4.25
Dividend Yield	4.43%
Dividend Growth (YoY)	8.6%
Payout Ratio	135.75%
Earnings Yield	4.77%
FCF Yield	5.05%

Dividend Details

Analyst Forecast

The average price target for SNY is $61.5, which is 20.8% higher than the current price. The consensus rating is "Buy".

Price Target	$61.5
Price Target Difference	20.8%
Analyst Consensus	Buy
Analyst Count	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$10.95
Lynch Upside	-78.49%
Graham Number	78.69
Graham Upside	54.6%

Stock Splits

The last stock split was on Sep 30, 2013. It was a forward split with a ratio of 5:1.

Last Split Date	Sep 30, 2013
Split Type	forward
Split Ratio	5:1

Scores

Altman Z-Score	1.9
Piotroski F-Score	6

Sanofi (SNY)